Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Company dna sagittarius ip
no operation time available
1 office
active in Legal Services

Scott Goodall has worked on the following 13 EPO patent applications which have been published in the last five years:

EP11764947

RADIOPROTECTOR COMPOUNDS AND METHODS

IPC classification:
A61K 31/4184, A61P 39/00, A61P 43/00, C07D 235/18
Agent:
Scott Goodall, Sagittarius IP
Status:
The patent has been granted
EP12712748

METHOD FOR PREPARING MULTIPLE ANTIGEN GLYCOPEPTIDE CARBOHYDRATE CONJUGATES

IPC classification:
A61K 39/00, A61K 47/48, C07K 9/00
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut Pasteur
Agent:
Scott Goodall, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14162956

Cysteine protease inhibitors

IPC classification:
A61K 31/16, A61P 11/00, A61P 37/00, C07C 237/14, C07D 233/58
Agent:
Scott Goodall, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13716919

USE OF NEUREGULIN TO TREAT PERIPHERAL NERVE INJURY

IPC classification:
A61K 38/16, A61K 38/17, A61K 38/18, A61P 25/02
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Scott Goodall, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13830653

PERFORIN INHIBITING BENZENESULFONAMIDE COMPOUNDS, PREPARATION AND USES THEREOF

IPC classification:
A61K 31/4035, A61K 31/404, A61K 31/4439, A61K 31/444, A61K 31/5377, A61P 3/10, A61P 37/06, C07D 401/10, C07D 409/10, C07D 409/14, C07D 417/14
Agent:
Scott Goodall, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14712964

THERAPEUTIC DOSING OF A NEUREGULIN OR A FRAGMENT THEREOF FOR TREATMENT OR PROPHYLAXIS OF HEART FAILURE

IPC classification:
A61K 38/18, A61P 9/00
Agent:
Scott Goodall, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14750516

FORM 2 CRYSTALLINE POLYMORPH OF A SALT OF N-[1-6-(ETHYNYL-3-OXO-HEXAHYDRO-FURO[3,2-B]PYRROLE-4-CARBONYL)-3-METHYL-BUTYL]-4-[5-FLUORO-2-(4-METHYL-PIPERAZINYL)THIAZOL-4-YL]-BENZAMIDE USEFUL AS CYSTEINE PROTEASE INHIBITOR

IPC classification:
A61K 31/496, A61P 19/00, C07D 491/048
Agent:
Scott Goodall, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14789434

HCV POLYMERASE INHIBITORS

IPC classification:
A61P 31/14, C07H 19/06, C07H 19/16
Agent:
Scott Goodall, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14802498

HCV POLYMERASE INHIBITORS

IPC classification:
A61K 31/7068, A61K 31/7072, A61P 31/14, C07H 19/06, C07H 19/10
Agent:
Scott Goodall, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11805571

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

IPC classification:
A61K 31/4178, A61K 31/4439, A61K 31/506, A61P 25/08, A61P 25/18, A61P 27/16, A61P 43/00, C07D 405/12, C07D 413/12, C07D 413/14
Agent:
Scott Goodall, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11794778

MYCOBACTERIUM ANTIGENIC COMPOSITION

IPC classification:
A61K 39/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15756888

DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/506, A61P 35/00, C07D 405/04, C07F 9/24
Agent:
Scott Goodall, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15763562

METHODS FOR THE PREPARATION OF DIASTEREOMERICALLY PURE PHOSPHORAMIDATE PRODRUGS

IPC classification:
C07H 1/04, C07H 19/10, C07H 19/20
Agent:
Scott Goodall, Sagittarius IP
Status:
Request for examination was made

Please Sign in to use this feature